| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ani Pharmaceuticals, Inc. (ANIP) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. ANIP is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 431.9K | $34.50M | - | |
| CEO | 411.2K | $32.85M | - | |
| VP | 158.5K | $12.66M | - | |
| Other | 91.3K | $7.29M | - | |
| VP | 84.0K | $6.71M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Mutz Christopher | Head Of Rare Disease | Sell | 6,500 | $57.70 | $375,050.00 | -7.8% | +4.6% | +48.5% | |
| Nov 13, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $61.36 | $15,340.00 | -0.4% | +0.0% | +41.3% | |
| Oct 14, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $57.19 | $14,297.50 | -0.4% | -7.8% | +51.7% | |
| Sep 13, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $56.82 | $14,205.00 | -0.4% | -3.3% | +67.0% | |
| Aug 13, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $59.62 | $14,905.00 | -0.4% | +4.7% | +50.5% | |
| Jul 18, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 2,743 | $62.00 | $170,066.00 | -0.4% | -2.8% | +8.1% | |
| Jul 17, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 47,257 | $63.73 | $3,011,592.12 | -2.4% | -7.0% | +8.0% | |
| Jul 12, 2024 | Cook Meredith49 | Sr. VP, General Counsel &Sec. | Sell | 250 | $64.91 | $16,227.50 | -0.4% | -13.2% | +2.3% | |
| Jul 1, 2024 | Gassert Chad60 | SVP - Corp. Dev. &Strategy | Sell | 20,000 | $63.44 | $1,268,800.00 | -9.4% | -6.0% | +0.2% | |
| Jun 21, 2024 | Shanmugam Muthusamy59 | Head Of R&D, Coo-novitium Ops | Sell | 20,000 | $58.90 | $1,178,000.00 | -2.8% | +3.2% | +12.0% |